Search the Newsreel

LifeStance Health director Teresa DeLuca sells $249,993 in shares By Investing.com

LifeStance Health Group director Teresa DeLuca sold 20,441 shares of the company's common stock for $249,993 on August 13, 2026, with the shares trading near their 52-week high after a significant gain. Despite this sale, management has been actively buying back shares, though InvestingPro's …

Great-West Lifeco (TSE:GWO) Shares Cross Above Two Hundred Day Moving Average - Here's Why

Lifeway Foods (NASDAQ:LWAY) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded Lifeway Foods (NASDAQ:LWAY) from "hold" to "sell," while Weiss Ratings also lowered its view to "hold," despite a broader analyst consensus of "Moderate Buy" with a $35 average price target. The company reported quarterly EPS of $0.01, missing estimates, though …

Precision Trading with Wave Life Sciences Ltd. (WVE) Risk Zones

This article from Stock Traders Daily provides a detailed analysis of Wave Life Sciences Ltd. (WVE), highlighting weak sentiment across all horizons supporting a short bias. It outlines institutional trading strategies, including long, breakout, and short positions, with specific entry zones, targets, and stop …

TriSalus Life Sciences (NASDAQ:TLSI) Cut to "Sell" at Wall Street Zen

Achieve Life Sciences (NASDAQ:ACHV) Stock Rating Lowered by Wall Street Zen

Achieve Life Sciences (NASDAQ:ACHV) recently had its stock rating lowered from "hold" to "strong sell" by Wall Street Zen. Despite this downgrade, the company still holds an average "Buy" rating from other analysts with a consensus target price of $15.00. Achieve Life Sciences, a …

Sun Life Financial (TSX:SLF) Unveils New Board Chair And Client Leadership Role

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Sun Life Financial (TSX:SLF) announced upcoming executive leadership changes, including a new chair of the Board and a new client focused executive role. …

LifeStance Health Surpasses Q2 Earnings Expectations Driven by Clinician Growth

LifeStance Health significantly exceeded Q2 earnings expectations, reporting $435.4 million in revenue and an adjusted EPS of $0.11, driven by a 26.1% year-over-year growth and improved operational efficiency. The company raised its full-year guidance for both revenue and EBITDA, reflecting strong management confidence. This …

Wave Life Sciences, Inc.: Revenue and Earnings Analysts Forecasts Revisions | WVE | US94352A1043

Lifeway Foods (NASDAQ:LWAY) Major Shareholder Edward Smolyansky Sells 35,000 Shares

Edward Smolyansky, a major shareholder in Lifeway Foods (NASDAQ:LWAY), sold 35,000 shares for $1.01 million, reducing his stake by 3.48%. This recent sale is part of a series of disposals totaling hundreds of thousands of shares since June. Despite the stock rising 4.5% to …

FitLife Brands (FTLF) Stock Drops As Margin Compression Clouds Growth

Lifeway Foods (LWAY) Stock Rises as Revenue Grows but Margins Tighten

Sun Life Preferred Shareholders Face Sept. 16 Conversion Deadline

Sun Life Financial Inc. announced it will not redeem its Class A Non-Cumulative Rate Reset Preferred Shares Series 10R and Class A Non-Cumulative Floating Rate Preferred Shares Series 11QR on September 30, 2026. Instead, holders of these preferred shares have the right to convert …

Sun Life Announces Conversion Privilege of Class A Non-Cumulative Rate Reset Preferred Shares Series 10R and Class A Non-Cumulative Floating Rate Preferred Shares Series 11QR

Sun Life Financial Inc. announced it will not redeem its Series 10R and Series 11QR preferred shares on September 30, 2026. As a result, shareholders have the option to convert their shares between these two series on a one-for-one basis, subject to minimum outstanding …

Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors

Edwards Lifesciences Corp. (EW) stock fell 1.04% on Friday, closing at $91.60. This underperformance occurred on a generally negative trading day for the stock market, with both the S&P 500 Index and the Dow Jones Industrial Average also declining. The stock experienced its third …

OceanLink Partners Fund (ATAT) discloses 4.72% holding in Atour Lifestyle

OceanLink Partners Fund, LP has disclosed a 4.72% beneficial ownership in Atour Lifestyle Holdings Ltd, consisting of 15,780,456 Class A ordinary shares, represented by 5,260,152 American Depositary Shares (ADSs). This filing, a Schedule 13G/A amendment, indicates OceanLink holds sole voting and dispositive power over …

Suja Life (SUJA): Vive Aggregator entities report over 3.9M shares under joint control

QP Vive Aggregator, LLC and Non-QP Vive Aggregator, LLC, collectively known as Vive Aggregator entities, have reported beneficial ownership of over 3.9 million shares of Suja Life (SUJA) Class A common stock through a Schedule 13G filing. QP Vive Aggregator holds 5.7% (2,199,173 shares) …

RPG Life Sciences accepts Deepak Shukla's resignation as API head

RPG Life Sciences completes API business transfer to subsidiary

Achieve Life Sciences (ACHV) launches $150M at-the-market stock program

Achieve Life Sciences (ACHV) has established a $150 million at-the-market (ATM) equity offering program with Jefferies LLC as the sales agent. The company plans to sell common stock periodically, with net proceeds intended for the commercialization of cytisinicline, funding a Phase 3 clinical trial …

Edward Smolyansky (LWAY) files to sell 75,000 shares after prior large sales

Edward Smolyansky has filed a Form 144 to sell up to 75,000 shares of LWAY common stock through Citigroup Global Markets Inc., with sales expected to begin on or after August 14, 2026. This filing follows several large sales of LWAY shares by Smolyansky …

Is MetLife (MET) Undervalued After Earnings And Its $3b Buyback?

Die Edwards-Lifesciences-Aktie steigt dank starker Q2-Dynamik und hoher Bewertung

TMC Life Sciences Berhad Declares First and Final Single-Tier Dividend in Respect of the Financial Year Ended 30 June 2026

What's Going On With Canadian Life Companies Split Corp Stock Friday?

LifeStance Health Group (NASDAQ:LFST) Given New $13.00 Price Target at JPMorgan Chase & Co.

JPMorgan Chase & Co. has raised its price target for LifeStance Health Group (NASDAQ:LFST) to $13.00 from $9.00, while maintaining a "neutral" rating. This new target implies a potential upside of 2.48% from the stock's previous close. The company recently reported strong quarterly earnings, …

LifeStance Health Group (LFST) Turned Profitable And Lifted Guidance, Is It Still Below Fair Value?

Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?

Edwards Lifesciences Corporation EW is entering the second half of 2026 with faster structural heart growth and better operating leverage. Second-quarter revenues rose 13.6% to $1.74 billion, while adjusted earnings increased 16.4% to 78 cents per share. The question is whether that momentum warrants …

What Are Wall Street Analysts' Target Price for Globe Life Stock?

Globe Life Inc. (GL) has outperformed the broader market, with its stock up 30.6% over the past 52 weeks and 29.4% YTD. Despite beating Q2 2026 earnings estimates, the stock dropped due to weak sales trends and underwriting performance. Analysts maintain a "Moderate Buy" …

Sun Life Financial Inc. stock rises Friday, outperforms market

Sun Life Financial Inc. (SLF) stock rose 0.13% to C$112.88 on Friday, outperforming the Canadian market as the S&P/TSX Composite Index (GSPTSE) fell 0.08%. The company's shares closed 5.1% below its 52-week high of C$118.99, achieved on July 28th.

TMC Life Sciences nearly doubles profit in 4Q, proposes 0.58 sen dividend

STANLEY: Revenue fell on B2B and retail headwinds, but margins held steady amid strategic transformation

TMC Life Sciences Berhad Posts Strong Earnings and Strengthens Balance Sheet in FY2026

Lifetime Brands (LCUT) Q2 2026 Earnings Call Transcript

Don't Race Out To Buy Clean Life Company (TADAWUL:9581) Just Because It's Going Ex-Dividend

HC Wainwright Analysts Boost Earnings Estimates for LifeMD

HC Wainwright analysts have increased their Q4 2027 earnings per share forecast for LifeMD to $0.17 from $0.15, while maintaining a "Buy" rating and a $9 price target. Despite this, analyst sentiment remains mixed with a "Moderate Buy" consensus rating but several recent downgrades. …